Ozaki K, Oda A, Wakao H, Rhodes J, Druker B J, Ishida A, Wakui M, Okamoto S, Morita K, Handa M, Komatsu N, Ohashi H, Miyajima A, Ikeda Y
Division of Hematology, Department of Internal Medicine, and Blood Center, Keio University, Tokyo, Japan.
Blood. 1998 Dec 15;92(12):4652-62.
Crkl, a 39-kD SH2, SH3 domain-containing adapter protein, is constitutively tyrosine phosphorylated in hematopoietic cells from chronic myelogenous leukemia (CML) patients. We recently reported that thrombopoietin induces tyrosine phosphorylation of Crkl in normal platelets. In this study, we demonstrate that thrombopoietin induces association of Crkl with a tyrosine phosphorylated 95- to 100-kD protein in platelets and in UT7/TPO cells, a thrombopoietin-dependent megakaryocytic cell line. With specific antibodies against STAT5, we demonstrate that the 95- to 100-kD protein in Crkl immunoprecipitates is STAT5. This coimmunoprecipitation was specific in that Crkl immunoprecipitates do not contain STAT3, although STAT3 becomes tyrosine phosphorylated in thrombopoietin-stimulated platelets. The coimmunoprecipitaion of Crkl with STAT5 was inhibited by the immunizing peptide for Crkl antisera or phenyl phosphate (20 mmol/L). After denaturing of Crkl immunoprecipitates, Crkl was still immunoprecipitated by Crkl antisera. However, coimmunoprecipitation of STAT5 was not observed. Coincident with STAT5 tyrosine phosphorylation, thrombopoietin induces activation of STAT5 DNA-binding activity as demonstrated by electrophoretic mobility shift assays (EMSA). Using a beta-casein promoter STAT5 binding site as a probe, we have also demonstrated that Crkl antisera supershift the STAT5-DNA complex, suggesting that Crkl is a component of the complex in the nucleus. Furthermore, interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor (GM-CSF), and erythropoietin also induce Crkl-STAT5 complex formation in responding cells in a stimulation-dependent manner. In vitro, glutathione S-transferase (GST)-Crkl bound to STAT5 inducibly through its SH2 domain. These results indicate that thrombopoietin, IL-3, GM-CSF, and erythropoietin commonly induce association of STAT5 and Crkl and that the complex translocates to the nucleus and binds to DNA. Interestingly, such association between STAT5 and Crkl was not observed in cytokine-stimulated murine cells, suggesting an intriguing possibility that components of the human STAT5-DNA complex may be different from those of the murine counterpart.
Crkl是一种含有SH2和SH3结构域的39-kD衔接蛋白,在慢性粒细胞白血病(CML)患者的造血细胞中持续发生酪氨酸磷酸化。我们最近报道,血小板生成素可诱导正常血小板中Crkl的酪氨酸磷酸化。在本研究中,我们证明血小板生成素可诱导血小板和UT7/TPO细胞(一种依赖血小板生成素的巨核细胞系)中Crkl与一种酪氨酸磷酸化的95至100-kD蛋白发生结合。使用针对STAT5的特异性抗体,我们证明Crkl免疫沉淀中的95至100-kD蛋白是STAT5。这种共免疫沉淀具有特异性,因为尽管STAT3在血小板生成素刺激的血小板中发生酪氨酸磷酸化,但Crkl免疫沉淀中不包含STAT3。Crkl与STAT5的共免疫沉淀被Crkl抗血清的免疫肽或苯基磷酸盐(20 mmol/L)抑制。Crkl免疫沉淀变性后,Crkl仍能被Crkl抗血清免疫沉淀。然而,未观察到STAT5的共免疫沉淀。与STAT5酪氨酸磷酸化一致,电泳迁移率变动分析(EMSA)表明血小板生成素可诱导STAT5 DNA结合活性的激活。使用β-酪蛋白启动子STAT5结合位点作为探针,我们还证明Crkl抗血清使STAT5-DNA复合物发生超迁移,表明Crkl是细胞核中该复合物的一个组成部分。此外,白细胞介素-3(IL-3)、粒细胞-巨噬细胞集落刺激因子(GM-CSF)和促红细胞生成素也以刺激依赖的方式在反应细胞中诱导Crkl-STAT5复合物的形成。在体外,谷胱甘肽S-转移酶(GST)-Crkl通过其SH2结构域可诱导性地与STAT5结合。这些结果表明,血小板生成素、IL-3、GM-CSF和促红细胞生成素共同诱导STAT5和Crkl的结合,且该复合物易位至细胞核并与DNA结合。有趣的是,在细胞因子刺激的小鼠细胞中未观察到STAT5与Crkl之间的这种结合,这提示了一种有趣的可能性,即人类STAT5-DNA复合物的组成成分可能与小鼠的不同。